Skip to content ↓

Topic

MIT Sloan School of Management

Download RSS feed: News Articles / In the Media / Audio

Displaying 1 - 15 of 501 news clips related to this topic.
Show:

Miami Herald

Prof. Stuart Madnick speaks with Miami Herald reporter Michelle Marchante about online phishing schemes. Madnick explains that while IP addresses can sometimes give a general idea of where a person was when they went online, it’s not a foolproof way to determine their exact location. He adds that anyone can buy a URL and redirect it to another website. 

New York Times

New York Times reporter Gina Ryder spotlights how Maria Paskowitz '96, MBA '02 and her neighbors have maintained a longstanding community tradition of transforming their Manhattan neighborhood into an open-air museum of Halloween art. This year Paskowitz has transformed “the exterior of the brownstone where she’s lived for the past decade into a colosseum,” writes Ryder. “She is collaborating with her neighbor, Elizabeth Styron, whose children, aged 9, 13 and 17, will dress as gladiators prepared for combat and a chariot race.” 

TechCrunch

Stwart Peña Feliz MBA '23 co-founded MacroCycle, a startup that has “devised a way to pluck desirable synthetic fibers from waste textiles, leaving everything else behind,” reports Tim de Chant for TechCrunch. “MacroCycle differs because it doesn’t break down polymers,” explains Tim de Chant. “Instead, it loops the polymer chains back on themselves, forcing them into rings called macrocycles. Those macrocycles remain behind as different solvents wash away contaminants, which themselves could be recycled. Later, the rings are reopened to reform the polymer chain.” 

STAT

Writing for STAT, Senior Lecturer Guadalupe Hayes-Mota 08, SM '16, MBA '16 examines how the closure of local pharmacies across the country poses a significant public health risk, particularly for Americans in rural communities who, like Hayes-Mota’s father, “depend on their local pharmacy not only for medicine, but for survival.” Hayes-Mota emphasizes that “addressing this crisis requires three urgent steps: supporting underserved areas with targeted incentives and mobile or telepharmacy services, investing in the workforce through safe staffing and career pathways, and granting pharmacists provider status with expanded scope of practice.”

Marketplace

Prof. Christopher Palmer speaks with Marketplace reporter Carla Javier about the rise in auto loan delinquencies, noting that defaulting on a car payment is usually a borrower’s last resort, since people often need cars to get to work, so they’re more likely to not pay other bills first. “That could include not paying their mortgages or their rent, in part because it takes a long time to evict someone or to foreclose on a house,” Palmer explains.

Time Magazine

Time reporter Brian Elliott spotlights Prof. Zeynep Ton’s comments at a recent conference regarding the importance of businesses having an employee-focused strategy when implementing new AI tools. “The status quo mindset in leaders is to see labor as a cost to be minimized,” Ton explains. “Exemplary companies think of employees as drivers of customer satisfaction, profitability and growth.”

Reuters

Vertical Semiconductor, an MIT spinoff, is working to “commercialize chip technology that can deliver electricity to artificial intelligence servers more efficiently,” reports Stephen Nellis for Reuters. “We do believe we offer a compelling next-generation solution that is not just a couple of percentage points here and there, but actually a step-wise transformation,” says Cynthia Liao MBA '24.

Wired

A new study by researchers at MIT suggests that “the biggest and most computationally intensive AI models may soon offer diminishing returns compared to smaller models,” reports Will Knight for Wired. “By mapping scaling laws against continued improvements in model efficiency, the researchers found that it could become harder to wring leaps in performance from giant models whereas efficiency gains could make models running on more modest hardware increasingly capable over the next decade.” 

Forbes

Writing for Forbes, Senior Lecturer Guadalupe Hayes-Mota '08, SM '16, MBA '16 emphasizes the importance of implementing ethical frameworks when developing AI systems designed for use in healthcare. “The future of AI in healthcare not only needs to be intelligent,” writes Hayes-Mota. “It needs to be trusted. And in healthcare, trust is the ultimate competitive edge.” 

Planet Money

Prof. Stuart Madnick speaks with Wailin Wong and Cooper Katz McKim of Planet Money about the growing problem of data breaches in the U.S., noting how AI is feeding into the problem. “We've seen several examples of how cyber attacks have been greatly accelerated due to AI tools,” Madnick explains. 

Financial Times

Writing for the Financial Times, Principal Research Scientist Florian Berg explores “reasons to be hopeful about the resilience of efforts to tackle environmental issues at the corporate level.” Berg explains: “When looking at reporting on carbon emissions, ESG data and money invested in sustainable investment strategies, we can see big increases in recent years.” 

WBUR

Prof. Pierre Azoulay speaks with WBUR’s Martha Bebinger about a new study examining the potential impact of NIH budget cuts on the development of new medicines. Azoulay and his colleagues found that “more than half of drugs approved by the FDA since 2000 used NIH-funded research that would likely not have happened if the NIH had operated with a 40% smaller budget,” Bebinger explains. 

Fierce Biotech

Fierce Biotech reporter Darren Incorvaia writes that a new study by MIT researchers demonstrates how potential NIH budget cuts could endanger the development of new medications. The researchers found that if the NIH budget had been 40% smaller from 1980 to 2007, the level of NIH cuts currently being proposed, “the science underlying numerous drugs approved in the 21st century would not have been funded,” Incorvaia explains. The findings suggest that “massive cuts of the kind that are being contemplated right now could endanger the intellectual foundations of the drugs of tomorrow,” explains Professor Pierre Azoulay. 

Genetic Engineering & Biotechnology News

A new study co-authored by MIT researchers finds that more than half of the drugs approved by the FDA since 2000 are connected to NIH research that would be impacted by proposed 40 percent budget cuts, reports Genetic Engineering & Biotechnology News

Boston.com

According to the U.S. News & World Report rankings for 2025-2026, MIT has been named the No. 2 best university in the United States, reports Madison Lucchesi for Boston.com